Literature DB >> 408422

Immunoepidemiology of meningococcal disease in military recruits. I. A model for serogroup independency of epidemic potential as determined by serotyping.

J M Griffiss, D D Broud, C A Silver, M S Artenstein.   

Abstract

One hundred twenty strains of Neisseria meningitidis were serotyped with use of cross-absorbed rabbit antisera in a bactericidal test. Fifty-eight epidemic strains of serogroup B, C, and Y that occurred simultaneously among military recruits at two basic training centers during a period of epidemic meningococcal disease were compared with 62 strains of serogroups A, B, C, and Y isolated worldwide. Antisera to the six original antigenic factors of the Gold serotyping schema were adequate for typing 94% of strains, including all of the epidemic strains. The array of serotyping factors in the epidemic strains differed from those in the nonepidemic strains. Epidemic strains were almost exclusively of two serotypes, with type CII predominant among strains of groups B and C. Concurrent strains of groups B and C were invariably of the same serotype. A model for the epidemic potential of meningococcal strains, which is based on their serotype and serogroup antigens, and a modification of the original Gold typing schema are presented.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 408422     DOI: 10.1093/infdis/136.2.176

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Rapid serotyping of groups A, B, and C meningococci by rocket-line immunoelectrophoresis and co-agglutination.

Authors:  D Danielsson; P Olcén
Journal:  J Clin Pathol       Date:  1979-02       Impact factor: 3.411

2.  Prevention of meningococcal disease: practice and prospects.

Authors:  T C Eickhoff
Journal:  West J Med       Date:  1978-03

Review 3.  The meningococcus and mechanisms of pathogenicity.

Authors:  I W DeVoe
Journal:  Microbiol Rev       Date:  1982-06

4.  Filter radioimmunoassay, a method for large-scale serotyping of Neisseria meningitidis.

Authors:  S de Marie; J H Hoeijmakers; J T Poolman; H C Zanen
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

5.  Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults.

Authors:  J M Griffiss; B L Brandt; P L Altieri; G B Pier; S L Berman
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

6.  Measurement of the human immune response to meningococcal lipooligosaccharide antigens by using serum to inhibit monoclonal antibody binding to purified lipooligosaccharide.

Authors:  M M Estabrook; R E Mandrell; M A Apicella; J M Griffiss
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

7.  Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man.

Authors:  W D Zollinger; R E Mandrell; J M Griffiss; P Altieri; S Berman
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

8.  Rapid serogroup identification of Neisseria meningitidis by using antiserum agar: Prevalence of serotypes in a disease-free military population.

Authors:  D E Craven; C E Frasch; L F Mocca; F B Rose; R Gonzalez
Journal:  J Clin Microbiol       Date:  1979-09       Impact factor: 5.948

9.  Heterogeneity of molecular size and antigenic expression within lipooligosaccharides of individual strains of Neisseria gonorrhoeae and Neisseria meningitidis.

Authors:  H Schneider; T L Hale; W D Zollinger; R C Seid; C A Hammack; J M Griffiss
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

10.  Immunological cross-reaction between a naturally occurring galactan, agarose, and an LPS locus for immune lysis of Neisseria meningitidis by human sera.

Authors:  J M Griffiss; D K Goroff
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.